Mereo Biopharma Group plc
SEC Filing List
MREO CIK: 0001719714
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SHARTSIS FRIESE LLP /fa | 05/15/2026 | |||
| 8-K | Current report filing | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/14/2026 | |
| SCHEDULE 13G | 05/14/2026 | ||||
| 8-K/A | Amendment to Current report filing | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| 8-K | Current report filing | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/12/2026 | |
| ARS | Annual report to security holders | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/09/2026 | |
| DEF 14A | Definitive proxy statements | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/09/2026 | |
| 8-K | Current report filing | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/27/2026 | |
| PRE 14A | Preliminary proxy statement not related ... | Mereo Biopharma Group Plc | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/27/2026 | |
| No record found. | |||||
| Load More | |||||
